Clinical trial
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
NCT00004832 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
- Lead sponsor
- FDA Office of Orphan Products Development
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 1994
- Completion date
- June 30, 1998
- Enrollment
- 26
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.